122 results on '"Lucioni, Alvaro"'
Search Results
2. PD24-06 EXCISION OF PELVIC FLOOR MESH VIA AN ABDOMINAL APPROACH HAS A HIGH SUCCESS RATE AND LONG-TERM PATIENT SATISFACTION
3. PD14-04 OPTIMIZING ANTIBIOTIC USE IN THE TREATMENT OF OVERACTIVE BLADDER: EVALUATING THE NEED FOR PROPHYLACTIC ANTIBIOTICS PRIOR TO ONABOTULINUMTOXINA INJECTION
4. V12-07 ROBOTIC-ASSISTED TRANSABDOMINAL REMOVAL OF ERODED MID-URETHRAL MESH SLING
5. V12-02 SACRAL NEUROMODULATOR OPTIMAL LEAD PLACEMENT TECHNIQUE
6. PD06-01 REAL WORLD OUTCOMES OF URETHRAL INJECTION OF POLYACRYLAMIDE HYDROGEL (BULKAMID®) FOR STRESS URINARY INCONTINENCE WITH INTRINSIC SPHINCTER DEFICIENCY, PRIOR URETHRAL SURGERY, OR PRIOR MESH SLING EXCISION
7. PD06-07 REAL-WORLD URINARY TRACT INFECTION RATES AND ANTIBIOTIC PRACTICE WITH URETHRAL INJECTION OF POLYACRYLAMIDE HYDROGEL (BULKAMID®)
8. MP01-20 A RANDOMIZED CONTROLLED TRIAL FOR OPIOID-LIMITING PAIN CONTROL AFTER TRANSURETHRAL RESECTION OF THE PROSTATE: MULTIMODAL PAIN REGIMEN WITH EDUCATIONAL INTERVENTION VERSUS STANDARD OF CARE
9. The Evolving Story of Mesh Mid Urethral Slings: The Surgeon’s Perspective
10. MP19-15 LISTENING TO WOMEN: A QUALITATIVE ANALYSIS OF WOMEN’S EXPERIENCES WITH MESH MID-URETHRAL SLING SURGERY
11. A Rapid Method to Preoperatively Assess Frailty for Older Patients with Pelvic Floor Conditions
12. MP27-04 ECONOMIC COST OF URINARY INCONTINENCE FOR INSURED ADULT MEN IN THE UNITED STATES: FINDINGS FROM THE UROLOGICAL DISEASES IN AMERICA PROJECT
13. MP30-06 LISTENING TO PATIENTS: WHAT IS IMPORTANT TO WOMEN REGARDING MID URETHRAL SLING SURGERY
14. MP30-14 MAJORITY OF ONABOTULINUMTOXINA-NAIVE PATIENTS WITH IDIOPATHIC OVERACTIVE BLADDER DO NOT REPEAT CHEMODENERVATION: FACTORS AFFECTING PATIENT DROPOUT AFTER INITIAL TREATMENT WITH 100 UNITS
15. Single Institutional Experience with Single Stage Sacral Neuromodulation: Cost Savings and Outcomes in a Contemporary Case Series
16. The Evolving Story of Mesh Mid Urethral Slings: The Surgeon's Perspective.
17. Incontinence after Prostate Treatment: AUA/SUFU Guideline
18. Do Patients Discontinue Overactive Bladder Medications after Sacral Neuromodulation?
19. Opioid Prescription and Use in Sacral Neuromodulation, Mid Urethral Sling and Pelvic Organ Prolapse Surgery: An Educational Intervention to Avoid Over Prescribing
20. MP61-19 ASSESSMENT OF CAREGIVER BURDEN AFTER URINARY DIVERSION FOR BLADDER CANCER
21. MP02-06 READABILITY OF PATIENT EDUCATION MATERIALS ON PELVIC ORGAN PROLAPSE, OVERACTIVE BLADDER, AND STRESS URINARY INCONTINENCE
22. Inconsistency in the Definition of Urinary Tract Infection after Intravesical Botulinum Toxin A Injection: A Systematic Review
23. PD32-10 OUTCOMES OF SACRAL NEUROMODULATION IN DETRUSOR HYPERACTIVITY WITH IMPAIRED CONTRACTILITY
24. MP75-17 DO PATIENTS DISCONTINUE OVERACTIVE BLADDER MEDICATIONS AFTER SACRAL NEUROMODULATION?
25. Use of Third Line Therapy for Overactive Bladder in a Practice with Multiple Subspecialty Providers—Are We Doing Enough?
26. PD17-09 FIVE-YEAR EXPERIENCE WITH PELVIC FLOOR MESH EXPLANT SURGERY: PATIENT CHARACTERISTICS AND PATIENT REPORTED OUTCOMES
27. MP40-15 USE OF THIRD LINE THERAPY FOR OVERACTIVE BLADDER IN A PRACTICE WITH MULTIPLE SUBSPECIALTY PROVIDERS: ARE WE DOING ENOUGH?
28. PD02-04 PRACTICE PATTERNS IN THE DIAGNOSIS AND TREATMENT OF FECAL INCONTINENCE WITH SACRAL NEUROMODULATION: CAN UROLOGISTS IMPACT THIS GAP IN CARE?
29. PD54-03 OPTIMIZING LEAD PLACEMENT DURING STAGED SACRAL NEUROMODULATION (SNM): FACTORS ASSOCIATED WITH PROGRESSION TO STAGE 2
30. PD28-05 LONG-TERM OUTCOMES OF MIDURETHRAL AND PUBOVAGINAL SLINGS FOR STRESS URINARY INCONTINENCE IN A TERTIARY REFERRAL SETTING
31. PD28-06 OUTCOMES OF AUTOLOGOUS RECTUS FASCIA PUBOVAGINAL SLING FOR SEVERE INTRINSIC SPHINCTER DEFICIENCY AND/OR RECURRENT STRESS URINARY INCONTINENCE: UP TO 11-YEAR FOLLOW-UP
32. MP75-08 THE VIRGINIA MASON TRANSITION TO A SECURE WEB-BASED DATABASE FOR MULTI-CENTER OUTCOMES EVALUATION
33. 2266 VOLUME AT URODYNAMIC DETRUSOR OVERACTIVITY PREDICTS SUCCESS WITH INTERSTIM
34. 1576 IS THERE A RELATIONSHIP BETWEEN INCONTINENCE IMPACT QUESTIONNAIRE 7 SCORE AFTER SURGERY FOR STRESS URINARY INCONTINENCE AND PATIENT-PERCEIVED SATISFACTION AND IMPROVEMENT?
35. 567 PATIENTS WITH COMPLEX STRESS URINARY INCONTINENCE ARE SATISFIED WITH LONG-TERM OUTCOMES FOLLOWING AUTOLOGOUS FASCIAL SLING SURGERY
36. 1575 HIGH RATE OF AMBIGUOUS AND MISSING DATA USING VALIDATED PATIENT-REPORTED OUTCOME QUESTIONNAIRES
37. 1360 LONG-TERM EFFICACY AND DURABILITY OF DURASHPERE® URETHRAL BULKING AFTER FAILED URETHRAL SLING FOR STRESS URINARY INCONTINENCE
38. 1873 IS THERE A RELATIONSHIP BETWEEN UROGENITAL DISTRESS INVENTORY 6 SCORE AFTER SURGERY FOR STRESS URINARY INCONTINENCE AND PATIENT-PERCEIVED SATISFACTION AND IMPROVEMENT?
39. 1178 LONG-TERM OUTCOMES OF THE MONARC® TRANSOBTURATOR
40. 1184 OUTCOMES OF TRANS-OBTURATOR TAPE: DO NULLIPAROUS WOMEN DO WORSE THAN PAROUS WOMEN?
41. 1363 SHOULD PATIENTS WITH “TYPE 0” STRESS URINARY INCONTINENCE UNDERGO SLING PLACEMENT?
42. 1702 PATIENT-REPORTED OUTCOMES FOLLOWING SURGERY FOR STRESS URINARY INCONTINENCE DIFFER DEPENDENT ON QUESTIONNAIRE
43. 1775 DURABLE LONG-TERM IMPROVEMENTS IN CONTINENCE WITH THE USE OF RETROPUBIC MID-URETHRAL POLYPROPYLENE SLING
44. 1768 CONCOMITANT PELVIC ORGAN PROLAPSE SURGERY DOES NOT AFFECT OUTCOMES OF RETROPUBIC MID-URETHRAL POLYPROPYLENE SLINGS
45. THE EFFECT OF BOTULINUM TOXIN A ON CHEMICAL STIMULATION OF RAT DORSAL ROOT GANGLION CELLS
46. VESICOVAGINAL FISTULA REPAIR WITH RECTUS ABDOMINIS MYOFASCIAL INTERPOSITION FLAP
47. Assessment of the Core Learning Objectives Curriculum for the Urology Clerkship
48. Current Use of Artificial Urinary Sphincters in the United States
49. V481: Spongioplasty Technique During Ventral Buccal Mucosa Onlay Graft Urethroplasty
50. V871: Advance Sling Placement in the Treatment of Post-Prostatectomy Urinary Incontinence
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.